Physician profile
Justin Floyd
NPI 1629164678
$9,282.50
in general payments reported to CMS, 2019-2025
59 companies · $2,102 in 2025
The $2,102 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,437 · 2020: $339 · 2021: $712 · 2022: $1,138 · 2023: $1,373 · 2024: $2,183 · 2025: $2,102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,541 · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,541.27 |
| Education | $116.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $956.26 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $763.41 | 2019-2025 | Opdivo, Opdualag |
| Emd Serono, INC. | $569.10 | 2019-2025 | Bavencio |
| Merck Sharp & Dohme LLC | $549.07 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Pfizer INC. | $513.99 | 2019-2025 | |
| Genentech USA, INC. | $458.98 | 2019-2025 | Polivy, Columvi, Lunsumio |
| Asd Specialty Healthcare, LLC | $381.86 | 2021-2024 | |
| Cardinal Health 108 LLC | $350.82 | 2024-2025 | |
| Janssen Biotech, INC. | $337.66 | 2019-2025 | Tecvayli, Talvey, Akeega |
| Genzyme Corporation | $274.56 | 2019-2025 | |
| Cardinal Health 110 LLC | $254.00 | 2025 | |
| US Oncology Corporate, INC. | $218.00 | 2024 | |
| Celgene Corporation | $204.28 | 2019-2025 | Reblozyl, Opdualag, Pomalyst |
| Amgen INC. | $203.12 | 2019-2023 | Blincyto, Kyprolis |
| Pharmacyclics LLC, An Abbvie Company | $201.32 | 2019-2023 | Imbruvica, Epkinly |
Show all 59 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Floyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.